Novartis Ag (NVS) Net Margin Growth (3y) (2012 - 2026)
Powered by 
Analysis
Novartis Ag (NVS) Net Margin Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn | -204.00 |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn | 666.00 |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn | 3,167.00 |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn | 240.00 |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn | -1,956.00 |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn | -1,144.00 |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn | 1,366.00 |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn | -94.00 |
| 10 | Jazz Pharmaceuticals | 16.02 Bn | 14.40 Bn | 1.09 Bn | 488.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 240.00 |
| Mar 31, 2026 | 639.00 |
| Dec 31, 2025 | 1,466.00 |
| Sep 30, 2025 | 1,217.00 |
| Jun 30, 2025 | 1,550.00 |
| Mar 31, 2025 | 1,444.00 |
| Dec 31, 2024 | -3,958.00 |
| Sep 30, 2024 | -45.00 |
| Jun 30, 2024 | 359.00 |
| Mar 31, 2024 | 729.00 |
| Dec 31, 2023 | -1,026.00 |
| Sep 30, 2023 | -793.00 |
| Jun 30, 2023 | 380.00 |
| Mar 31, 2023 | 311.00 |
| Dec 31, 2022 | -7,880.00 |
| Sep 30, 2022 | -287.00 |
| Jun 30, 2022 | -4,454.00 |
| Mar 31, 2022 | -120.00 |
| Dec 31, 2021 | 380.00 |
| Sep 30, 2021 | 702.00 |